Zabofloxacin hydrochloride (DW-224a) exhibits potent antibacterial activity against Gram-positive pathogens, including Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae; it is a novel fluoro-naphthyridone quinolone antibiotic used as an alternative agent for studying quinolone-susceptible (QSSP) and quinolone-resistant (QRSP) gonorrhea.